Panel miRNAs are potential diagnostic markers for chronic kidney diseases a systematic review and meta-analysis /
Background: Accurate detection of kidney damage is key to preventing renal failure, and identifying biomarkers is essential for this purpose. We aimed to assess the accuracy of miRNAs as diagnostic tools for chronic kidney disease (CKD). Methods: We thoroughly searched five databases (MEDLINE, Web o...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2024
|
| Sorozat: | BMC NEPHROLOGY
25 No. 1 |
| Tárgyszavak: | |
| doi: | 10.1186/s12882-024-03702-y |
| mtmt: | 35172537 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/35434 |
| LEADER | 02727nab a2200313 i 4500 | ||
|---|---|---|---|
| 001 | publ35434 | ||
| 005 | 20241231105802.0 | ||
| 008 | 241231s2024 hu o 000 eng d | ||
| 022 | |a 1471-2369 | ||
| 024 | 7 | |a 10.1186/s12882-024-03702-y |2 doi | |
| 024 | 7 | |a 35172537 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a eng | ||
| 100 | 1 | |a Gantsetseg Garmaa | |
| 245 | 1 | 0 | |a Panel miRNAs are potential diagnostic markers for chronic kidney diseases |h [elektronikus dokumentum] : |b a systematic review and meta-analysis / |c Gantsetseg Garmaa |
| 260 | |c 2024 | ||
| 300 | |a 14 | ||
| 490 | 0 | |a BMC NEPHROLOGY |v 25 No. 1 | |
| 520 | 3 | |a Background: Accurate detection of kidney damage is key to preventing renal failure, and identifying biomarkers is essential for this purpose. We aimed to assess the accuracy of miRNAs as diagnostic tools for chronic kidney disease (CKD). Methods: We thoroughly searched five databases (MEDLINE, Web of Science, Embase, Scopus, and CENTRAL) and performed a meta-analysis using R software. We assessed the overall diagnostic potential using the pooled area under the curve (pAUC), sensitivity (SEN), and specificity (SPE) values and the risk of bias by using the QUADAS-2 tool. The study protocol was registered on PROSPERO (CRD42021282785). Results: We analyzed data from 8351 CKD patients, 2989 healthy individuals, and 4331 people with chronic diseases. Among the single miRNAs, the pooled SEN was 0.82, and the SPE was 0.81 for diabetic nephropathy (DN) vs. diabetes mellitus (DM). The SEN and SPE were 0.91 and 0.89 for DN and healthy controls, respectively. miR-192 was the most frequently reported miRNA in DN patients, with a pAUC of 0.91 and SEN and SPE of 0.89 and 0.89, respectively, compared to those in healthy controls. The panel of miRNAs outperformed the single miRNAs (pAUC of 0.86 vs. 0.79, p < 0.05). The SEN and SPE of the panel miRNAs were 0.89 and 0.73, respectively, for DN vs. DM. In the lupus nephritis (LN) vs. systemic lupus erythematosus (SLE) cohorts, the SEN and SPE were 0.84 and 0.81, respectively. Urinary miRNAs tended to be more effective than blood miRNAs (p = 0.06). Conclusion: MiRNAs show promise as effective diagnostic markers for CKD. The detection of miRNAs in urine and the use of a panel of miRNAs allows more accurate diagnosis. | |
| 650 | 4 | |a Farmakológia és gyógyszerészet | |
| 700 | 0 | 1 | |a Nagy Rita |e aut |
| 700 | 0 | 1 | |a Kói Tamás |e aut |
| 700 | 0 | 2 | |a Nguyen Do To Uyen |e aut |
| 700 | 0 | 2 | |a Gergő Dorottya |e aut |
| 700 | 0 | 2 | |a Kleiner Dénes |e aut |
| 700 | 0 | 2 | |a Csupor Dezső |e aut |
| 700 | 0 | 2 | |a Hegyi Péter |e aut |
| 700 | 0 | 2 | |a Kökény Gábor |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/35434/1/s12882-024-03702-y.pdf |z Dokumentum-elérés |